Skip to main content

Epidural Analgesia Has No Effect on Maternal Temperature


July 27, 2012 — Contrary to previous studies, there’s no significant relationship between epidural anesthesia and an increase in maternal body temperature during labor, according to a new study published in the August issue of Anesthesiology.
In contrast, the study, by Michael A. Frölich, MD, from the Department of Anesthesiology at the University of Alabama at Birmingham, and colleagues, did find significant associations between temperature increase during induced labor and both higher body mass index (P = .0067) and longer time from rupture of membranes to delivery (P = .0077).
Reports over recent years suggest that possible causes of noninfectious maternal temperature elevations during labor include epidural analgesia, endogenous heat production by uterine contractions, and overheated delivery rooms. The authors sought to evaluate the first possible cause by conducting a prospective cohort trial.
Of 90 women with induced labor who were enrolled in the study, 1 was excluded because of a clinical diagnosis of chorioamnionitis, and 4 were excluded because they received acetaminophen for intrapartum pain. An additional 4 participants were excluded because of the availability of less than 4 hours of data. A total of 81 women undergoing induced labor were therefore included in the analysis.
Labor lasted an average of 11 hours and 41 minutes. All but 3 of the women received epidural analgesia. The median duration of epidural analgesia was 7.9 hours (interquartile range, 4.3 - 12.1 hours).
The authors found that temperature increased with length of labor. They calculated a very small average temperature trend, with an increase of 0.017°C/hour (P = .0093) over the course of 10 hours of labor. The population slope was calculated using the linear mixed model, β1.
Fever in laboring women was not associated with epidural analgesia. The authors did note, however, the absence of a temperature drop in the first 4 hours after initiation of epidural anesthesia.
The authors found a significant association between the time of rupture of membranes to delivery and body mass index (P = .0475).
Previous studies have reported maternal temperature elevations in women who received epidural analgesia in association with placental inflammation, neonatal sepsis work-up, pregnancy-induced hypertension, labor progress, and mode of delivery.
Numerous theories have been proposed as to why the temperature increases occur during so many different labor circumstances. In a press release, Dr. Frölich stated, "Long labor sustains an inflammatory process that may result in a temperature elevation. Also, the same mechanism may be responsible for patients who are overweight, since the link between obesity and inflammation is well established."
The authors propose that future research focus on better understanding the exact causes of noninfectious maternal intrapartum fever to help identify and treat women who are more prone to fever during labor.
The authors have disclosed no relevant financial relationships.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

Obama Renominates Tavenner to Be CMS Chief

President Barack Obama yesterday renominated Marilyn Tavenner, the acting administrator of the Centers for Medicare & Medicaid Services (CMS), to serve in that post without the caveat of "acting" attached to it. If the Senate approves her nomination, Tavenner will be the first confirmed, full-fledged CMS administrator since Mark McClellan, MD, PhD, stepped down from that position in October 2006, during the George W. Bush administration. Dr. McClellan's successors either were acting administrators or, in the case of Donald Berwick, MD, who was Tavenner's immediate predecessor, a recess appointment. As illustrated by Dr. Berwick's  CMS history , Senate confirmation can be tough to get when one party has enough votes to filibuster and otherwise stymie a nomination by an opposing party's president. That was the case when Obama nominated Dr. Berwick, whom Senate Republicans portrayed as an advocate of healthcare rationing, a characterization denied by t...

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction. [1]  Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD. [1]  Heart failure is the fastest-growing clinical cardiac disease ...